In addition, TSC2−/− MEFs displayed dramatically increased S6K phosphorylation at basal levels, which could be reversed by re-expressing WT, but not two TSC disease-associated mutant forms of TSC2, suggesting that TSC2 loss promotes mTORC1 activation [83]. The gene discussed is TSC2; the disease is tuberous sclerosis.